Navigation Links
Arizona companies team up, providing quick development of cancer drugs
Date:1/26/2011

FLAGSTAFF, Ariz. Jan. 26, 2011 TGen Drug Development (TD2) and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.

TD2, based in Scottsdale, Ariz., provides drug development firms with expertise in moving promising laboratory discoveries through the pre-clinical, clinical and regulatory approval steps of getting new drugs to patients as quickly and safely as possible.

Flagship Biosciences, based in Flagstaff, Ariz., will greatly assist in this process by providing high-throughput, multiplexed immunohistochemistry expertise to support preclinical drug development and human clinical trials.

"Flagship's technology will significantly accelerate our ability to identify biomarkers that could help researchers predict which drug compounds will work best on specific patient cancers," said TD2 President Dr. Stephen Gately.

And because Flagship's affiliated laboratories are certified by the U.S. Food and Drug Administration, under the 1988 federal Clinical Laboratory Improvement Amendments (CLIA) law, these findings can be translated directly into clinical trials, where they can benefit patients as quickly as possible.

Specifically, Flagship provides computerized histopathology, the microscopic study of diseased tissue, which is a critical part of anatomical pathology and key to the accurate diagnosis of cancer and other diseases from sample tissues. Flagship also provides deep expertise in measuring epithelialmesenchymal transition (EMT), the process in which tumor cells become highly invasive, migratory and resistance to therapy.

"The local tumor environment is key to understanding efficacy and toxicity of oncology compounds in both preclinical and clinical trials, and EMT is central to understanding stromal involvement and fibrosis in cancer patients," said Dr. Gately. "Working with Flagship Biosciences brings a
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Experts converge at Arizona State University for first preventive cancer vaccine conference
2. ASU professor named top in state of Arizona
3. NIH funds center at Arizona State to battle infectious diseases
4. University of Arizona-led group awarded $9.9 million to develop super rice
5. New research will unravel Arizonas prehistoric puzzle of the Hohokam ceramic industry
6. First Arizona Strides for Life event nets $25,000 for TGen research
7. TGen provides Arizona with $77 million in annual economic impact
8. DOE funds bio-inspired solar fuel center at Arizona State
9. Reportlinker Adds Biomarkers - technologies, markets and companies
10. TGen Drug Development accompanies GPEC to BayBio2010
11. Study highlights sustainable footprint of chemical companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... consume the healthcare community and remain priority ... To address the worldwide crisis of obesity ... global leaders in diabetes, epidemiology and public ... and development of diverse intervention programs in ... This book on "Global Health Perspectives in ...
(Date:7/25/2014)... diffusion tensor tractography (DTT), which is derived from ... for three motor tracts, such as the corticospinal ... became possible. The corticospinal tract is known to ... in the human brain. Several studies have reported ... herniation. In addition, some studies have demonstrated recovery ...
(Date:7/25/2014)... have detected an unknown interaction between microorganisms and salt. ... a droplet of salt water and is left to ... biomineralogical biosaline 3D morphologically complex formations, where they hibernate. ... The discovery was made by chance with a home ... Astrobiology journal and may help to find signs ...
Breaking Biology News(10 mins):What constitutes an effective response to the global 'diabesity' tsunami? 2Bacteria manipulate salt to build shelters to hibernate 2
... 2, 2014 EcoHealth Alliance, a nonprofit organization ... issues, and Bat Conservation International, which works to ... are joining forces in formal partnership. The organizations ... and public health programs that enhance outreach with ...
... N.C. A new Duke University-led study has documented dramatic, ... estuary. "The natural short-term variability in acidity ... global predictions for the ocean as a whole and may ... organisms, particularly shelled organisms that are especially susceptible to changes ...
... centuries as a pain reliever in Chinese medicine may be ... chronic pain. A key pain-relieving ingredient is a compound known ... plant Corydalis , a member of the poppy family, ... Press journal Current Biology on January 2. ...
Cached Biology News:EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues 2Local factors cause dramatic spikes in coastal ocean acidity 2Plant used in Chinese medicine fights chronic pain 2
(Date:7/25/2014)... York (PRWEB) July 25, 2014 According ... Research, "Biological Drugs Market - Global Industry Analysis, Size, ... global biological drugs market is estimated at USD 161,056.5 ... a CAGR of 10.1% from 2014 to 2020, to ... 2020. , The biological drugs market is witnessing a ...
(Date:7/25/2014)... The Conferee Networking committee is pleased to ... These two-hour sessions provide a unique networking opportunity for ... discuss new techniques, or brainstorm new ideas in an ... for consideration is August 31, 2014, and instructions can ... committee will review the topics, and status notifications will ...
(Date:7/25/2014)... , July 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, today announced financial results for the period ... Financial Summary: , Reported cash and cash equivalents ... $137,000 at December 31, 2013.  , Reported a ...
(Date:7/25/2014)... July 25, 2014 At the request ... granted a 60-day extension for the public comment period ... Rule for Model Aircraft established by Congress as part ... The 60-day extension establishes the new deadline for comments ... Department of Transportation/FAA notice published in the Federal Register ...
Breaking Biology Technology:Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6FAA Grants Comment Extension at the Request of AMA 2
... Biopharmaceuticals,Inc. (Nasdaq: KERX ) will hold a conference ... to discuss the Third Quarter 2007 financial results.,Michael S. ... will,host the call. Keryx will announce its financial results ... prior to the call. In order to participate ...
... Positive Phase I Results for R1507, COPENHAGEN, October ... from a Phase I study of R1507 in patients,with ... a human,monoclonal antibody targeting the insulin-like growth factor receptor,(IGF-1R) ... Nine of 34 adult patients with solid tumors experienced ...
... Calif., Oct. 23 InVitria has released ... factor for cell culture,media outperforms transferrin and ... Because Lacromin is produced in a completely,animal-free ... over,animal-derived alternatives including bovine and human transferrin. ...
Cached Biology Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT 2Phase I Results Announced for R1507 From Genmab's Collaboration With Roche 2Phase I Results Announced for R1507 From Genmab's Collaboration With Roche 3InVitria's Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin 2
...
Request Info...
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
The FliTrx Panning Kit is designed to simplify panning for protein-protein interactions with the FliTrx Random Peptide Display Library or the pFliTrx Peptide Display Vector....
Biology Products: